Denise M Scholtens

Medicine & Life Sciences

1. Mothers 100%
2. Hyperglycemia 66%
3. Pregnancy Outcome 65%
4. Adiposity 59%
5. Glucose 58%
6. Pregnancy 56%
7. Newborn Infant 47%
8. Metabolomics 44%
9. Gestational Diabetes 44%
10. Breast Neoplasms 44%
11. Glioblastoma 43%
12. Birth Weight 36%
13. Breast 35%
14. Glioma 32%
15. Genes 31%
16. Methylation 30%
17. Fasting 29%
18. Neoplasms 29%
19. C-Peptide 28%
20. Fetal Blood 28%
21. Insulin Resistance 22%
22. Health Care Outcome Assessment 22%
23. Genome-Wide Association Study 20%
24. Parturition 20%
25. acylcarnitine 19%
26. Biomarkers 19%
27. Nipple Aspirate Fluid 18%
28. Carcinoma, Intraductal, Noninfiltrating 18%
29. Survival 16%
30. Gene Expression 16%
31. Estrogen Receptors 16%
32. Synucleins 15%
33. Hormones 14%
34. Brain Neoplasms 14%
35. Metabolome 14%
36. Proteins 14%
37. Type 2 Diabetes Mellitus 14%
38. Glucose Tolerance Test 14%
39. Blood Pressure 13%
40. Carcinoma 13%
41. Ovarian Neoplasms 13%
42. Single Nucleotide Polymorphism 13%
43. DNA Methylation 12%
44. Hyperinsulinism 12%
45. Health 12%
46. Nipples 12%
47. Annexin A7 12%
48. Confidence Intervals 12%
49. Alleles 12%
50. Genome 12%